Nutent Therapeutics, Inc.

Delivering patient value through its portfolio of scientific-data driven products

  • Stage Prototype Ready
  • Industry Consumer Products
  • Location Boca Raton, FL, US
  • Currency USD
  • Founded January 2017
  • Employees 1
  • Incorporation Type C-corp
  • Website nutenttherapeutics.com

Company Summary

Nutent is the first company to promote their nutraceutical portfolio through the support of scientific data. Nutent is currently generating revenue via the launch of Volt03 and GlucodOX. Volt03 was approved by Health Canada in 2019

VOLT03 is a new formulation of curcumin that has demonstrated superior efficacy to pure curcumin & indomethacin in animal studies. It is the only product to show Anti-aging effects in a published pre-clinical trial.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free